Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR2 | P21452 | 9/20 | 0.72 |
| ▸ | TACR1 | P25103 | 7/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.44 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.44 |
| ▸ | TACR3 | P29371 | 3/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7719849 | 0.99 | TACR2 (0.71) | TACR2TACR1CHRM2CHRM3TACR3 | |
| SCHEMBL4631147 | 0.88 | TACR2 (0.81) | TACR2TACR1CHRM2CHRM3TACR3 | |
| SCHEMBL6976267 | 0.87 | TACR2 (0.84) | TACR2TACR1CHRM2CHRM3TACR3 | |
| SCHEMBL4631279 | 0.86 | TACR2 (0.85) | TACR2TACR1CHRM2CHRM3TACR3 | |
| Hydrochloric Acid SCHEMBL7749084 | 0.86 | TACR2 (0.79) | TACR2TACR1CHRM2CHRM3TACR3 | |
| Hydrochloric Acid SCHEMBL7749204 | 0.85 | TACR2 (0.83) | TACR2TACR1CHRM2CHRM3TACR3 | |
| SCHEMBL6959954 | 0.85 | TACR2 (0.68) | TACR2TACR1CHRM2CHRM3TACR3 | |
| SCHEMBL4630052 | 0.85 | TACR2 (0.64) | TACR2TACR1CHRM2CHRM3TACR3 | |
| SCHEMBL4630232 | 0.84 | TACR2 (0.79) | TACR2TACR1CHRM2CHRM3TACR3 | |
| SCHEMBL4631736 | 0.84 | TACR2 (0.74) | TACR2TACR1CHRM2CHRM3TACR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1140923-B1 | METHOD FOR PREPARING (R)- (+) -3 1- 2-( 4-BENZOYL- 2-(3,4- DIFLUOROPHENYL)MORPHOLIN- 2-YL)ETHYL]- 4-PHENYLPIPERIDIN -4-YL -1,1- DIMETHYLUREA, ITS SALTS SOLVATES AND/OR HYDRATES | SANOFI SYNTHELABO (FR) | 2003-03-05 | — | — | EP | claimed |
| US-6392039-B1 | COUPLING; SALT FORMATION | SANOFI-SYNTHELABO (FR) | 2002-05-21 | — | — | US | claimed |
| EP-1140923-A1 | METHOD FOR PREPARING (R)- (+) -3 1- 2-( 4-BENZOYL- 2-(3,4- DIFLUOROPHENYL)MORPHOLIN- 2-YL)ETHYL]- 4-PHENYLPIPERIDIN -4-YL -1,1- DIMETHYLUREA, ITS SALTS SOLVATES AND/OR HYDRATES | SANOFI-SYNTHELABO (FR) | 2001-10-10 | — | — | EP | claimed |
| WO-2000039126-A1 | METHOD FOR PREPARING (R)- (+) -3 {1- [2-( 4-BENZOYL- 2-(3,4- DIFLUOROPHENYL)MORPHOLIN- 2-YL)ETHYL]- 4-PHENYLPIPERIDIN -4-YL}-1,1- DIMETHYLUREA, ITS SALTS SOLVATES AND/OR HYDRATES | SANOFI-SYNTHELABO (FR) | 2000-07-06 | — | — | WO | claimed |
| EP-1140923-B1 | METHOD FOR PREPARING (R)- (+) -3 1- 2-( 4-BENZOYL- 2-(3,4- DIFLUOROPHENYL)MORPHOLIN- 2-YL)ETHYL]- 4-PHENYLPIPERIDIN -4-YL -1,1- DIMETHYLUREA, ITS SALTS SOLVATES AND/OR HYDRATES | SANOFI SYNTHELABO (FR) | 2003-03-05 | — | — | EP | disclosed |
| US-6392039-B1 | COUPLING; SALT FORMATION | SANOFI-SYNTHELABO (FR) | 2002-05-21 | — | — | US | disclosed |
| EP-1140923-A1 | METHOD FOR PREPARING (R)- (+) -3 1- 2-( 4-BENZOYL- 2-(3,4- DIFLUOROPHENYL)MORPHOLIN- 2-YL)ETHYL]- 4-PHENYLPIPERIDIN -4-YL -1,1- DIMETHYLUREA, ITS SALTS SOLVATES AND/OR HYDRATES | SANOFI-SYNTHELABO (FR) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000039126-A1 | METHOD FOR PREPARING (R)- (+) -3 {1- [2-( 4-BENZOYL- 2-(3,4- DIFLUOROPHENYL)MORPHOLIN- 2-YL)ETHYL]- 4-PHENYLPIPERIDIN -4-YL}-1,1- DIMETHYLUREA, ITS SALTS SOLVATES AND/OR HYDRATES | SANOFI-SYNTHELABO (FR) | 2000-07-06 | — | — | WO | disclosed |